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Acute pain from vaso-occlusion that cannot be reduced at home is the most common reason for 
Emergency Department (ED) visits and hospital admission for patients with Sickle Cell Disease 
(SCD).  Administration of opioids is often necessary to alleviate pain symptoms.  Despite health-
care provider’s knowledge of pain episodes that occur in individuals with SCD, poor pain 
management persists in the health care setting.  This may be due to preconceptions and 
misinformation regarding administration of opioids and general lack of SCD knowledge.  The 
availability of personal computers and access to the World Wide Web in the home and office 
settings allows for web-based learning as an efficient and convienient method to reach many 
health-care providers.  Clinicians can access concisely presented information that covers the 
most essential information, and that provides instantaneous access to relevant literature.  
Consequently, we developed a web-based, interactive educational module that describes a typical 
presentation and course of a pediatric patient with SCD presenting to the ED with pain.  The 
purpose of this project is to assess whether this type of educational intervention is useful, 
accessible and effective for enhancing health care provider’s knowledge.  To measure degree of 
knowledge gained, we compared answer selections from a 5-question pre-test and post-test.  An 
evaluation was administered containing two demographic questions and nine opinion questions.  
Opinion questions asked subjects to what degree they felt a particular objective was achieved.  
 iv 
Answers choices were based on a Likert-type scale ranging from “very low” to “very high”.  A 
variety of health care providers have participated in this project, ranging from social workers to 
hematology attending physicians.  Subjects reported feeling a web-based application was useful 
and that the overall quality of our module was very good.  Under-treatment of pain in all patient 
populations is a public health problem.  In the SCD patient population pain episodes recur over a 
lifetime and significantly impact all areas of life.  Web-based educational modules similar to the 
one we have created can augment knowledge and refine health care providers’ practice of pain 
management in SCD to improve efficacy, thereby increasing quality of life for these patients. 
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1.0  INTRODUCTION 
The clinical hallmark of Sickle cell disease (SCD) is acute pain that occurs from vascular 
occlusion. (Ballas 2005) Pain episodes recur unexpectedly and without warning over a lifetime, 
often requiring intervention by the Emergency Department (ED) with administration of opioids 
for alleviation of pain sensation.  Despite the development of management guidelines by the 
Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and the American 
Pain Society (APS), it is well established that effective pain management continues to be a 
problem for all patient populations. (Rupp and Delaney 2004; Todd KH 2007) This is especially 
troubling for patients with SCD.  Unlike post-surgical or cancer-related pain, individuals with 
SCD experience acute pain episodes throughout their lifetime.  This leads to developing 
tolerance to typical doses of opioids due to chronic exposure.  Although clinicians are aware of 
pain episodes that occur in SCD patients, poor pain management practices persist.  This often 
results from a complex cycle of preconceptions and misinformation regarding management of 
pain with opioids, paired with health care providers’ limited knowledge of SCD and failure of 
institutional guidelines for effective pain management in SCD to be understood by health care 
providers. (Yadgood, Miller et al. 2000) Clinicians’ misinformation is paired with patient anxiety 
that stems not only from pain sensation but also from anticipation of not being believed by health 
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care providers.  This can perpetuate a cycle of inefficient pain management as tension increases 
between provider and patient.   
The Comprehensive Hemoglobinopathy Program at Children’s Hospital of Pittsburgh has 
provided multidisciplinary care to children with SCD since 1978 and provides care for over 200 
children each year.  The program is made up of a team of Hematology experts including 
physicians, nurse practitioners, social workers, and behavioral health specialists.  The primary 
goal of this program is to identify children with SCD early in life and effectively manage their 
condition.  One step in achieving that goal was to create an algorithm that describes a step-wise 
management protocol to help streamline and focus pain management for patients with SCD 
presenting to the ED with a pain episode from vaso-occlusion.  This algorithm has been 
implemented into Children’s Hospital of Pittsburgh’s Guidelines for Clinical Effectiveness 
(Appendix D).  
There is a need to augment health care providers’ knowledge regarding effective pain 
management from vaso-occlusive crisis.  Additionally, increased recognition of the signs and 
symptoms of life-threatening circumstances that can occur secondary to pain episodes will allow 
clinicians to better understand how to efficiently tackle pain stemming from vaso-occlusive crisis 
as well as develop effective strategies for treating their patients with SCD.  In an effort to 
promote the algorithm and to provide an opportunity for health care providers to enhance their 
understanding of Sickle cell disease, we have created an interactive, web-based educational 
module that follows a patient and his mother through their visit to the ED due to pain from vaso-
occlusion.  Using the algorithm as a guide, users must answer questions regarding effective 
management of the patient’s pain episode. 
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The purpose of study was to assess whether an interactive, web-based, educational 
module would enhance health care providers ability to manage acute pain from vasooclusion in 
patients with SCD.  Our intent was to create an educational module that was concise, accessible, 
and appealing to the user.  By addressing the four aims listed below, we measured both 
knowledge gained and assessed subjects’ opinions of this type of media to improve their 
knowledge, attitudes and efficacy in caring for SCD patients who present to the ED with acute 
pain from vasooclusive crisis. 
 
Aim 1: Assess whether health care providers have increased knowledge of management of 
acute pain from vaso-occlusion in patients with SCD. 
Aim 2: Determine whether health care providers will alter they way they manage patients 
with SCD presenting to the ED or to their clinical practice with pain following the use 
of this educational module. 
Aim 3: Determine health care providers overall attitudes about web-based educational 
modules. 
Aim 4: Assess whether this type of educational tool helped health care providers to learn 
and understand the established CHP algorithm (Guidelines for Clinical Effectiveness) 
for managing vaso-oclusive pain in patients with Sickle cell disease.   
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2.0  
2.1 
BACKGROUND AND SIGNIFICANCE 
SICKLE CELL DISEASE 
Sickle cell disease (SCD) is a term used to describe group of inherited conditions that cause a 
change in the structure or quantity of the hemoglobin molecule.  Hemoglobin is a tetramer 
comprised of two alpha globin subunits and two beta globin subunits.  Mutations in the HBB 
gene can cause abnormal conformation of the beta globin subunit, or beta chain.  In particular, a 
point mutation at the second nucleotide of the sixth codon of the beta chain will cause an amino 
acid substitution of valine for glutamic acid.  This mutation causes an abnormal structural variant 
of hemoglobin referred to as Hb S.  When an individual is homozygous for this particular point 
mutation, they have Sickle cell anemia (Hb SS).  Sickle cell anemia is the most common and 
typically the most severe form of Sickle cell disease.  Other mutations in the HBB gene lead to 
other abnormal versions of beta hemoglobin.  These include hemoglobin C and hemoglobin E.  
Mutations that cause a decrease in the amount of beta globin produced are called beta 
thalassemias.  Compound heterozygosity of Hb S with other atypical forms of hemoglobin can 
cause Sickle cell disease variations such as SC disease, SE disease, or Sickle/Beta thalassemia.  
(Wilson, Krishnamurti et al. 2003)  In this document the term Sickle cell disease will refer to any 
variation of Sickle cell disease.  All forms of Sickle cell disease (SCD) are autosomal recessive 
hemoglobinopathies that are characterized by chronic hemolytic anemia and vascular occlusion.    
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Mutations in the HBB gene causing SCD are most often seen in individuals with African, 
Mediterranean, Middle Eastern, Indian, Caribbean, and Central and South American ancestry 
although the condition can be found in individuals with any ethnic background.  Among African 
Americans, SCD is diagnosed in approximately 2000 live births annually.  This translates to 
about 1 in 250-600 African Americans with the condition.  (Shafer, Lorey et al. 1996) 
2.1.1 Pathophysiology of Sickle Cell Disease 
The primary function of hemoglobin is to transport oxygen molecules from the lungs to the rest 
of the body.  In individuals with SCD this function is hindered due to the effects of vascular 
occlusion and hemolytic anemia.  Vascular occlusion is associated with the hallmark symptom of 
SCD: the acute painful episode.  The process of vaso-occlusion is complex, but may be broadly 
described by two events; the polymerization of the hemoglobin S molecule within erythrocytes 
and adhesion of red blood cells to the endothelium of blood vessels.  (Hebbel 2000) When red 
blood cells that contain hemoglobin S become deoxygenated valine residues are able to “dock” 
to neighboring beta chains causing the formation of an irregular, “sickled” shape.  (Stuart and 
Nagel 2004)  Consequently, the survival of a red blood cell may be reduced from 120 to as low 
as 20 days.  (Wilson, Krishnamurti et al. 2003) Polymerization also affects the deformability of 
red blood cells.  The other key process that occurs in concert with polymerization is adhesion of 
red cells to the endothelium of blood vessels.  Adhesion occurs due to a response of the 
endothelium to various signals such as hypoxia, thrombin, and platelet activating factor or 
interleukin-1.  (Hebbel 2000)  Adherence of reticulocytes and dense, poorly deformable red cells 
to the epithelium will impede blood flow, increasing transit time.  This in turn causes local 
anemia from increased red cell turnover.   (Stuart and Nagel 2004)  
 
Figure 1. Pathophysiology of Vaso-occlusion. (Stuart and Nagel 2004) 
2.1.2 Clinical Features of Sickle Cell Disease 
Sickle cell disease is a chronic condition that is associated with a myriad of symptoms that stem 
from vascular occlusion and hemolytic anemia.  Hemolysis can cause anemia, jaundice, 
pulmonary complications, cholelithiasis, delayed growth and sexual maturation.  Vascular 
occlusion causing tissue ischemia can result in organ damage and dysfunction. 
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Painful episodes in SCD are complex and can manifest as acute or chronic events.  Pain 
symptoms may be the result of vascular occlusion, secondary to other symptoms of SCD, like leg 
ulcers or priapism, or result from various treatments of the condition that cause withdrawal 
symptoms or post-operative pain.  (Ballas 2005)  However, the primary clinical feature of sickle 
cell disease is the acute, vaso-occlusive painful episode that requires the use of opioids for 
alleviation of pain sensation.  Vascular occlusion can occur anywhere in the body, likewise pain 
sensation can be felt anywhere over the body.  The most common areas involved in pain events 
include the chest, back, abdomen and limbs.   Dactylitis, or “hand-foot syndrome” is often the 
first clinical sign of SCD.  It presents as a painful swelling of the hands and feet due to vaso-
occlusion of the vasculature in this area and may predict a more severe disease course.  (Miller, 
Sleeper et al. 2000)  Effective pain management in childhood shapes a patient’s coping 
mechanisms as they get older.  As a result, pain should be assessed from a multidisciplinary 
approach when possible, taking into consideration the life experiences of each patient.  (Ballas 
2005) 
Infection is linked to many complications associated with SCD.  Despite preventative 
measures such as prophylactic penicillin regimens and pneumococcal vaccination, sepsis remains 
a major concern for patients with SCD and is a common cause of death. (National Institutes of 
Health 2002)  Susceptibility occurs due to splenic infarcts that cause malfunction.  Prophylactic 
penicillin administered daily to children with SCD has shown to reduce the cases of 
Streptococcus pneumoniae sepsis by 80%.  (Gaston, Verter et al. 1986)  For children who do not 
have a history of pneumococcal infection or splenectomy daily, prophylactic penicillin can be 
stopped at age 5.   In addition to all routine vaccinations including the 7-valent pneumococcal 
conjugate vaccine (Prevnar), children with SCD should also receive the 23-valent polysaccharide 
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pneumococcal vaccine (PPV).  Individuals with SCD should also receive annual influenza and 
semi-annual meningococcal vaccination.  (Mehta, Afenyi-Annan et al. 2006)  Due to the 
increased risk for sepsis, febrile SCD patients with fever of 38.5 degrees Celsius or greater are is 
an emergency situation.  Patients should be evaluated by the Emergency Department, have blood 
cultures drawn immediately, followed by administration of IV antibiotics.  Evaluation should 
include a physical exam, chest x-ray and blood counts. 
The risk for stroke is a major complication with SCD, particularly for individuals with 
SCD-SS (Sickle cell anemia).  Neurological complications may include cerebral infarcts or 
intracranial hemorrhage.  Cerebral infarcts occur most commonly in children with the first 
recognized cerebral event occurring between the ages of 2-5.  (Wong and Powars 2005)  
Seventeen percent of children with SCD who do not have any neurological symptoms have 
changes that can be detected on magnetic resonance imaging. (Mehta, Afenyi-Annan et al. 2006)  
These changes may be associated with learning and behavioral difficulties and may indicate an 
increased risk for more severe brain ischemia in the future.  Lifetime risk for SCD patients for a 
cerebral infarction is 30%. (Wong and Powars 2005) Strokes occur due to relentless 
polymerization of Hb S and endothelial changes that lead to a narrowing of the vasculature.  
Annual screening using transcranial Doppler ultrasonography is recommended for patients with 
SCD-SS beginning at age 2.  Increased blood flow velocity of 200 cm/s or greater on transcranial 
Doppler indicates significant stenosis and therefore an increased risk for stroke.  Transfusion 
therapy should be considered for these patients.  (Wong and Powars 2005) 
Pulmonary complications including acute chest syndrome and pulmonary hypertension 
are major life-threatening concerns for patients with SCD.  Pulmonary problems not directly 
caused by vaso-occlusion, like pneumonia or asthma can exacerbate SCD due to local or 
 9 
 
systemic hypoxia that increases polymerization of Hb S, leading to a complex cycle of health 
concerns.   
Diagnosis of acute chest syndrome (ACS) is made in the presence of a new pulmonary 
infiltrate on a chest x ray with chest or back pain, a temperature of more than 38.5 degrees 
Celsius, tachypnea, wheezing or cough.  (Vichinsky, Neumayr et al. 2000)  ACS is the second 
most common cause for hospitalization and the leading cause of morbidity and mortality in 
patients with SCD.  The cause of ACS is multifactorial, but is commonly associated with 
pulmonary infarcts due to fat embolism from bone marrow infarcts.  Infectious agents, including 
Streptococcus pneumoniae and parvovirus B19, are also associated with ACS.  The strongest risk 
factor for development of ACS is hemoglobin genotype.  Patients with HbSS have the highest 
incidence, while patients with sickle/beta thalassemia (HbS/β+) have the lowest incidence.  
Treatment recommendations for ACS include administration of oxygen, blood transfusion, 
antibiotics, pain control and spirometry.  Assessment of blood oxygen requires comparison of 
baseline arterial blood gases to current arterial blood gases to estimate the alveolar-arterial 
gradient.  Repeated monitoring of the A-a gradient is a good predictor of clinical severity of 
ACS.  Bronchodilator therapy may also be helpful to increase oxygenation for some patients.  
Exchange transfusion will decrease the proportion of sickle red cells and increase the oxygen 
affinity of blood.  Intravenous broad-spectrum antibiotics should be given upon diagnosis of 
ACS or febrile patients due to difficulty in excluding bacterial pneumonia.  Incentive spirometry 
can prevent hypoventilation in individuals with ACS and can reduce the development of ACS in 
individuals with vaso-occlusive pain. (Vichinsky, Neumayr et al. 2000) 
It has been shown that 32% of adult SCD patients exhibit pulmonary arterial 
hypertension, a complex and life-threatening complication of SCD.  (Gladwin, Sachdev et al. 
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2004)  Children also exhibit pulmonary hypertension.  Although there is not enough data to 
support overall incidence in the pediatric population, at least one study as has show a correlation 
with low hemoglobin, elevated reticulocyte count, and cerebral vasculopathy. (Ambrusko, 
Gunawardena et al. 2006) The underlying pathophysiology of pulmonary hypertension remains 
to be completely elucidated although it is likely multifactorial.  Hb S polymerization decreases 
deformability and increases fragility of erythrocytes causing their premature breakdown yielding 
hemolysis.  Hemolysis interferes with nitric oxide (NO) synthesis and utilization, which causes 
dysfunction of the vasculature including NO resistance, initiation of platelet and tissue factors, 
vasoconstriction, and vaso-proliferation.  (Castro and Gladwin 2005)  Chronic hemolysis is a risk 
factor for pulmonary hypertension.  As a result, individuals with HbSS genotype are more likely 
to acquire pulmonary hypertension than someone with Hb SC genotype.  Screening involves the 
use of a transthoracic Doppler echocardiogram that measures tricuspid regurgitant jet velocity 
(TRV).  A TRV value of 2.5m/sec or greater is considered a clinically significant elevation 
suggesting an increased risk for morbidity and mortality from pulmonary hypertension. 
(Ambrusko, Gunawardena et al. 2006)  Pulmonary arterial pressures of 5mmHg and 15mmHg 
are estimated to have vaso-constriction of greater than 50% and less than 50%, respectively.  In 
one study the median survival with pulmonary hypertension (25mmHg) was 2.8 years.  (Castro 
and Gladwin 2005)  Management and treatment of pulmonary hypertension are still being 
determined but will likely involve Hydroxyurea therapy, exchange transfusion, iron chelation 
therapy, and vasodilators dilators including prostacyclins. (Gladwin, Sachdev et al. 2004; Castro 
and Gladwin 2005)  
Acute splenic sequestration is a relatively common and potentially life-threatening 
condition caused by accumulation irregular red cells by the spleen.  (Aquino, Norvell et al. 1997) 
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Confinement of blood in the splenic sinusoids causes splenomegaly, a significant drop in 
hemoglobin level, and the potential for hypoxic shock.  Acute splenic sequestration typically 
occurs between ages 3 months and 5 years, but can occur at any age.  Individuals with Hb SS 
typically present with acute splenic sequestration early in childhood, while those with Hb SC 
typically present with symptoms later in childhood.  Patients and caretakers should be informed 
of the importance and method of palpating the spleen.  (Aquino, Norvell et al. 1997) Splenic 
sequestration can be diagnosed with an acute decrease of 2g/dl of hemoglobin from average 
baseline hemoglobin, elevated reticulocyte count as compared to baseline counts, and enlarged 
spleen greater than baseline measurements.  Clinical symptoms associated with splenic 
sequestration may include: weakness, pallor, and tachycardia.  Treatment is aimed at restoring 
circulating blood volume with transfusion.  Due to the high rate of recurrence, spleen 
management in young children often involves chronic transfusion and/or splenectomy.  Issues to 
consider when making decisions regarding management should include the risk for infection 
following splenectomy, consideration of whether chronic transfusions will restore splenic 
function, and ability of the child’s caregivers to identify, react, or access care during subsequent 
splenic sequestration.   
Other major health complications for individuals with SCD include: dysfunction of 
biliary tract and liver, renal changes, priapism, leg ulcers, and bone complications.  Gall bladder 
and liver problems likely stem from chronic hemolysis.  This causes an increase in bilirubin 
production and incidence of gall stones.  Almost 30% of patients with SCD develop gall stones 
by age 18.  Treatment involves the use of antibiotics with the option of cholecystectomy.  Liver 
involvement may be caused by vascular occlusion or chronic hepatitis.  Exchange transfusion is 
the most commonly used treatment option.   
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2.2 
The kidney is especially at risk for organ damage from Hb S polymerization and vaso-
occlusion due to the local environment that is hypoxic, acidic, and hypertonic.  Hyposthenuria is 
the most common renal complication in SCD.  As a result these individuals are also at increased 
risk for dehydration, which is a risk factor for vaso-occlusive pain event.  Patients should be 
encouraged to always stay hydrated.  Other changes in the kidney result in proteinuria and 
hematuria.  Both conditions overtime can be life-threatening, treatment for some patients may 
ultimately involve kidney transplant.  (Ataga and Orringer 2000)   
Priapism in males with SCD is caused by vaso-occlusion that causes obstruction of the 
venous drainage of the penis.  Priapism is a common complication for males with SCD, with 
89% of males experiencing at least one episode by age 20.  (Mantadakis, Cavender et al. 1999)  
Treatment may include IV hydration, analgesics, or penile aspiration of blood.   
Bone marrow hyperplasia from chronic hemolytic anemia, vaso-occlusive episodes 
causing bone infarcts, and sepsis resulting in osteomyelitis are the primary causes of bone 
complications for patients with SCD and are a mail cause of morbidity.  Another common 
complication for individuals with SCD is the occurrence of leg ulcers.  Although their etiology is 
unclear, they occur in 10-20% of patients with SCD.   
PAIN MANAGEMENT IN THE EMERGENCY DEPARTMENT 
Despite published guidelines for pain management by organizations such as JCAHO, and ample 
availability of effective pain medication and other therapies in health care settings, 
undertreatment, or oligoanalgesia, in emergency medicine continues to be a major public health 
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problem. (Berry and Dahl 2000; Phillips 2000; Rupp and Delaney 2004)  Inadequate pain 
management in hospital settings was brought to the forefront following a 1973 article by 
psychiatrists Marks and Sachar. (Marks RM 1973)  Since that time a plethora of literature has 
been produced stating similar findings that poor pain management continues to be recognized, 
and continues to be inadequate.  Pain that continues to be ineffectively managed has 
physiological and psychological effects directly impacting overall quality of life. (Ballas, Barton 
et al. 2006)  Chronic pain can impact family dynamics, social relationships, and employment 
status.  Inadequate pain relief creates a financial burden on the health care system and on society 
costing millions of dollars annually as a result of longer hospital stays, re-hospitalizations, and 
emergency department visits.  Individuals who are unable to work may lose income as well as 
insurance coverage, further perpetuating the public health dilemma.  Although efforts by the 
Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and other accrediting 
organizations to create standardized treatment guideline for managing pain in the Emergency 
Department have been established, recent literature describes little improvement. (Todd KH 
2007)   
 The acute pain episode is the most frequent complication in patients with SCD and is 
associated with diminished quality of life. (Benjamin, Swinson et al. 2000)  Pain episodes are 
unpredicable, notoriously intense, and continue to recur over a lifetime.  Effective pain 
management for patients presenting to the ED with SCD and other chronic illnesses continues to 
be a struggle in many institutions.  There are several proposed reasons for this.  One reason is 
that health care providers have preconceived ideas regarding patients seeking analgesia, or 
inappropriate concern for causing addiction in patients. (Rupp and Delaney 2004) It has also 
been proposed that poor pain management may stem from a lack of emphasis in medical school 
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curriculums or residency programs. (Augarten A 2006) Another explanation is the absence of 
tangible proof of pain in conditions like SCD may lead physicians to under-appreciate the 
magnitude of the pain episode.  (Elander J 2006)  Additionally, there is general lack of 
understanding of SCD and consequently poor appreciation of how to effectively manage pain in 
patients with chronic exposure to opioids. (Benjamin, Swinson et al. 2000) 
2.2.1 Opioid use in pain management 
Opioid agonists are commonly used in management of pain episodes for patients with SCD.  
Opioid agonists achieve pain reduction by decreasing the perception of pain by the central 
nervous system.  Adverse effects of this class of narcotics include itching, nausea, vomiting, 
sedation, seizures and respiratory depression.  Opioids have no ceiling effect, where eventually 
doses no longer have an additive effect.  As a result, the only reason to limit opioid 
administration in a patient is concern for the adverse effects listed above. (Ballas 2005) 
2.2.2 Pain Management Acute Vaso-occlusive Pain Episode and Discriminating Between 
Analgesic Dependence, Tolerance, Addiction and Psuedoaddiction 
In one of her numerous articles published in 1980 Margo McCaffery, RN, MS said, "Pain is 
whatever the experiencing person says it is, existing whenever he says it does."  (McCaffery 
1980)  This simple and elegant statement captures the subjective nature of pain sensation nicely.  
Inappropriate misconceptions regarding drug addiction may account for many cases of poor 
management of pain.  Analgesic dependence and tolerance occur after chronic use of a drug 
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causes physiological changes.  Tolerance occurs when a particular dose loses its effectiveness 
and desired effects can only be achieved with larger doses.  Dependence occurs when a 
physiological change occurs in the body where withdrawal symptoms, such as sweating, nausea, 
diarrhea, vomiting or seizures occur when the drug is no longer taken.  Genuine analgesic 
addition among patients complaining of pain is rare.   Addiction may occur with or without 
physiological responses.  Addiction is the compulsive desire to take analgesics for effects other 
than pain relief.  It is differentiated from dependence in that individuals exhibit behavior that 
indicates a compulsive need to have the drug.  (McCaffery and Hart 1976; Shapiro BS 1994)    
Pseudoaddiction occurs when a patient historically has had poorly managed pain in the health-
care setting.  These individuals resort to behaviors that resemble drug-seeking behavior and are 
interpreted as such by health-care providers.  This cycle of poorly managed pain and 
manipulative behavior by patients in a pain episode undermine trust between groups, further 
compromising effective pain management.  (Lusher, Elander et al. 2006) 
Health care providers who treat pain are influenced by contextual factors that surround 
the interaction between patient and provider.  Inaccurate perception and overestimation of 
addiction may be attributed because of the resemblance of certain pain behaviors that resemble 
symptoms of analgesic addiction.  This in turn can lead to increased anxiety during visits to the 
emeregency department and displays of pseudoaddiction in patients with SCD.  Patients must 
resort to exaggerated or manipulative behavior in order to persuade health care providers to 
administer appropriate analgesics.  (Elander J 2006)  Pain episodes in SCD are unique in that 
they are recurrent over a lifetime and typically don’t present with objective, verifiable symptom.  
Most conditions that exhibit pain occur as a one time event, either acutely (following surgery) or 
chronically (as in cancer).  Patients who experience pain episodes as one time events do not have 
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the opportunity to learn coping mechanisms as patient with SCD do, that can cause another layer 
of complexity for health-care providers who must differentiate between dependence and abuse 
(Lusher, Elander et al. 2006). 
In 2006, Elander, et al. published a vignette study where health care providers were asked 
to examine fictious patients with SCD who displayed genuine symptoms of analgesic addiction 
and pain behaviors that resemble those symptoms.  Providers judged pain level, likelihood of 
addiction, and the analgesic needs.  The results showed that providers were able to distinguish 
between true addictive behavior and behaviors that resemble addiction.  However, no differences 
were seen in the decisions regarding amount of required analgesia needed for both sets of 
patients.  Health care providers treated patients they correctly identified with behaviors only 
resembling addictive behavior (pseudoaddiction), with less powerful or less frequent analgesics.  
Health-care providers who practice oligoanalgesia will further perpetuate anxiety and behaviors 
of pseudoaddiction in patients.   Health care providers (nurses and doctors) with more experience 
in treating patients with SCD made higher estimates of analgesic needs indicating that a deeper 
understanding and appreciation for the condition yields more rigorous treatment of pain in 
patients with SCD.  Elander concluded that staff training should emphasize less on formal 
knowledge of SCD and more on practical experience in making assessments of patients who 
require analgesia. (Elander J 2006)       
2.2.3 Hydroxyurea 
Hydroxyurea is a chemotherapeutic drug that can reduce the number to SCD-related 
complications including acute chest syndrome, and lowering number of pain episodes by 50%.  
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(Ballas, Barton et al. 2006)  The exact mechanism of how hydroxyurea works is unclear however 
effects on the bone marrow include an increase in the synthesis of fetal hemoglobin (Hb F). 
(Charache, Terrin et al. 1995)  Historically, it was the observation of patients with persistently 
high HbF levels and milder disease course that lead to the addition of hydroxyurea as a treatment 
option.  This makes sense as Hb F does not have a beta globin subunit, it is a tetramer comprised 
of to alpha and two gamma globin chains.  Due to the cytotoxic nature of this drug, it is unclear 
what the long-term effects will be.  With that in mind, hydroxyurea is prescribed to pediatric 
patients who present with a more severe disease course.   
2.2.4 Pain Management and Effect on Quality of Life 
“…pain is not equal to or reducible to vao-occlusion.  Pain is a multifaceted, complex, and 
inherently subjective experience.  The physiologic process of vaso-occlusion may initiate and 
maintain the experience of pain, but the pain cannot be reduced to the pathophysiology.” 
(Shapiro B 1993)  To provide effective manangement of pain in SCD, health care providers must 
have complete understanding of the issues associated with the treatment of pain of an incurable 
disease on a chronic basis.  Pain in SCD is not unlike other types of pain where it is a complex 
human experience.  Strongly influenced by social, cultural and spiritual experiences.  As a result, 
pain management becomes more effective as health care providers learn to know their patients 
beyond the initial triage questions.  (Ballas 2005)  
Health-related quality of life is a layered concept that includes physical, emotional, and 
psychosocial pieces associated with a disease or treatment.  Poor pain management in the 
emergency department (ED) can impact all areas of life for individuals with Sickle cell disease. 
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(Ballas 2005)  Maintaining a high quality of life in patients with a chronic disese and chronic 
pain is difficult.  Individuals who live with recurrent, acute pain episodes are known to have 
increased risk for mental health problems, lower performance at work, and general lower quality 
of life. (Ballas, Barton et al. 2006)  Additionally, children with SCD exhibit lower performance 
at school and impaired social interaction. The chronic, lifelong nature of SCD and it’s impact on 
all areas of life can be best treated with a multidisiplinary approach by providers that know their 
SCD well, addressing phyical, emotional and psycosocial needs.   (Fuggle, Shand et al. 1996; 
Benjamin, Swinson et al. 2000) 
Although the understanding of the pathophysiology of SCD continues to become more 
and more clear, and many advances are achieved in availability of treamtent and management 
options to alleviate symptoms, basic principles of pain mangement are not employed by many 
sickle cell experts.  Clinical features are not well understood by pain specialists, and many 
physicians and nurses lack general basic knowledge of SCD and pain management.  It is well 
recognized that ineffective pain management increases morbidity.  Furthermore, there is an 
association with number of pain episodes per year and mortality. (Benjamin, Swinson et al. 
2000) Despite efforts by JCAHO to establish pain assessment guidelines and make pain the “fifth 
vital sign” to increase awareness by health care providers that pain is an important and 
undertreated symptom, changes in intervention or improvements in treating pain has not been 
acomplished by all institutions. (Narasimhaswamy, Vedi et al. 2006)  New methods must be 
explored to execute changes in practice by health care providers treating pain in SCD.    
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2.3 WEB-BASED LEARNING 
As medical education continues to expand into alternative delivery methods, web-based learning 
has emerged as a teaching opportunity to make education more accessible and more relevant to 
learners.  Web-based learning provides several advantages.  It provides an efficient and 
convienient method to reach many health-care providers.  The vast availability of personal 
computers, faster Internet connections, and the use of the World Wide Web and other electronic 
resources as instant references, makes web-based learning a seamless addition to traditional 
teaching methods.  Additionally, web-based education would allow some learners to gain insight 
into topic areas that they do not have much practical experience, and allow more seasoned 
providers an opportunity to learn more about the latest advances in treatment—all with 
instantaneous access. 
Compared to traditional teaching, web-based learning provides an opportunity to review 
complex topics using an interactive method that provides links to relevant literature, and concise 
didactic segments that cover the most essential information.  Typically, learners will access 
educational modules when it is convenient for them, allowing for a more relaxed, and thorough 
learning experience.      
2.3.1 The Virtual Patient 
Professional development of health-care providers is achieved by quality learning, training, and 
problem-solving.  Often much of this development occurs as providers begin to interact with 
patients.  Unfortunately, for a variety of reasons this interaction is limited.  Out-patient care, 
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ethical considerations, unwillingness of patients, and scarcity of certain types of patients prevent 
continued development of problem-solving skills, and training.  One way to provide learners an 
opportunity for increased experience is by creating a virtual patient experience.   
Virtual patients can use a problem-solving approach where the learner must gather 
information from physical exam, labs, or medical history and then diagnose or manage the 
patient.  Virtual patients may also have a narrative approach that follows a storyline.  Virtual 
patients allow for repetitive, non-judgmental practice of clinical skills by the learner.  This 
provides an environment where mistakes are allowed, and safety is maintained for patients and 
providers.  A web-based platform is an effective medium to utilize virtual patient cases.  
Changes and refinements can be continually addressed, more than one learner can access the 
application at one time, and applications can be access at any time.  Additionally, the application 
is installed onto a server to that learners do not have to bother with software components, and 
finally cases may be utilized by an infinite amount of individuals, allowing for wide distribution 
of information.  
2.3.2 Learning Styles and Web-based Learning 
It is well established that there are a variety of learning styles that influence the way that people 
learn and interpret information.  If teaching methods are different from learning style, this could 
negatively affect the learners’ performance.  (Curry 1999)  As web-based educational 
applications reach large, heterogeneous populations, the variety of learning styles could 
potentially have an impact on effectiveness and adaptation of the application by learners.  In 
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2005 David Cook, MD published an article that reviewed various styles of learning and 
considered their relationship to web-based education applications.  (Cook 2005) 
The wholist-analytic dimension described by Cook is derived from various studies that all 
classify learning styles.  This dimension describes how these individuals interpret various 
situations to understand the educational message.  They see a unified whole, or as a collection of 
individual parts.  Wholists are guided by a broader frame of reference while analytics extract 
clues from the overall picture that allow for step-wise learning.  In terms of web-based 
education, analytics appear to perform better when there is less structure, and there is 
encouragement for detailed investigation before garnering the overall message.  Wholists 
perform better when there is some structure and direction through an educational application.  
Additionally, wholists may benefit from more discussion based interaction, where there is more 
social interaction with other learners. (Cook 2005) 
The verbalizer-imager dimension encompasses several descriptions of learning and 
cognitive style.  Cognitive style describes personal attributes like perception, memory, and 
judgment that be related to educational contexts and non-educational contexts.  Verbalizers, as 
the name insinuates, learn best from speech and written text.  Socially, verbalizers will be better 
communicators and will likely only tolerate stimulating presentation.  Imagers learn best from 
pictures and demonstration.  They are described as better than verbalizers at keeping track of 
their location in space, which could translate into better performance in a complex, web-based 
application.  Imagers are further described as more likely to tolerate tasks they find unappealing.  
On the surface it would seem that verbalizers would perform better in web-based applications 
that were text-heavy and more directed, while imagers would do well with more multi-media and 
hyperlinks, without being distracted by a potentially convoluted path through cyberspace.  The 
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evidence however among medical education, is mixed.  There is no significant identified 
difference in scores between these groups.  Evidence could be confounded if there are a higher 
proportion of certain types of learners in the health-care field. 
The concrete-abstract dimension describes how information is acquired and then 
processed.  Knowledge acquisition is either concrete though the senses, or abstract by analyzing.  
The concrete learner prefers learning from experience and example, while the abstract learner 
prefers concepts and theory.  Preferred instructional method for the concrete learner would 
involve case-based learning with interactive demonstration.  The use of factual information 
would favor abstract learners.  Limited evidence has not demonstrated difference in performance 
by these two learning styles.  Adaptation in instructional method may provide more impact on 
learning than changes to presentation or environment of a web-based program.   
The active-reflective dimension describes how learners use the knowledge they have 
gained.  Active learners are more apt to utilize the information without consideration of the 
implications.  Reflective learners tend to observe, internalize, and examine different perspectives 
as they assimilate the information.  Due to the independent and self-paced nature of web-based 
education, reflective learners would seem to enjoy and perform better with this type of learning.  
The exception to this would be if an application required several interactive features that would 
disrupt the reflective learners need for time to process the information.  Interactive features 
would however suit the needs for an active learner.  Limited evidence available indicates that 
active learners do indeed perform better than reflective learners in web-based learning formats.   
There is literature to support that different types of learners perform better when teaching 
methods are adapted to specific learning style.  Information is limited due to the dearth of 
research in this area, small sample sizes, and differing educational applications.  Cook 
 23 
 
recommends that future web-based studies measure variation in design, presentation and 
teaching method, rather than focusing on whether learners perform better tradition or computer-
based methods. (Cook 2005) 
2.3.3 Educational Intervention on Pain Management in the Emergency Department 
Patients presenting to the ED with pain typically have some level of anxiety that is either 
produced by the underlying cause for the pain or due to past experiences in the health care 
setting.  Pain is historically undertreated, this causes increased anxiety for patients with SCD 
who live with a chronic condition that causes recurrent pain episodes over a lifetime.  In a study 
performed by a group in Israel, pain management in the ED improved substantially following 
educational interventions.  The most significant improvement in management was achieved 
following a one day course in pain management that included a lecture and patient simulation 
with actors. (Augarten A 2006) 
Health care provides in the Emergency department (ED) are familiar with a fast-paced, 
unpredictable, need-to-know working environment.  This is inherently problematic when 
providers are then asked to implement a change in their practice, or to take time to participate in 
continuing education.  Shift work hours, and unpredictable patient flow can create barriers to 
traditional teaching methods.   Web-based educational applications can provide an effective 
alternative for enhancement or continuing education for health care providers in the ED.  Health 
care workers had an increased response to a web-based learning experience compared to face to 
face workshops or lectures.  Although workshops were designed based on requests of workers, 
attendance was often low.  The ability for individuals to access the educational application at a 
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time that was convenient for them was likely a contributing factor. (Curran-Smith and Best 
2004) 
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3.0  
3.1 
MATERIALS AND METHODS 
PROJECT DEVELOPMENT 
This project has come to fruition as a result of collaboration between the Comprehensive 
Hemoglobinopathy Program at Children’s Hospital of Pittsburgh (CHP) and the Laboratory for 
Educational Technology (LET) at University of Pittsburgh School of Medicine.  Following 
meetings and discussion to mold the desired educational product, the first major step of was to 
develop learning objectives for the educational module.  The objectives provide an outline of 
content to be included in the case, and were derived from CHP’s Guidelines for Clinical 
Effectiveness entitled, “Sickle Cell Disease Vasocclusive Crisis in the ED Pain Management”.  
The guidelines are structured as an algorithm to provide a step-wise method for treating pain in 
patients with Sickle cell disease.  The guidelines were created by a group of Sickle cell experts 
including Dr. Lakshmanan Krishnamurti, Director of the Comprehensive Hemoglobinopathy 
Program and other team members of the Comprehensive Hemoglobinopathies Program at CHP.   
The next step was writing and developing the case that would serve as the foundation of 
our educational module.  The case of a young boy presenting the Emergency department (ED) 
was written to be a succinct, accurate, typical presentation of a patient with SCD presenting to 
the ED with pain.  Additionally, the case is written to be appropriate for any health-care provider 
who cares for patients with SCD; physicians, nurses, social workers, and so forth.  Users of the 
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educational module are informed they are a pediatric Emergency Medicine resident.  The 
storyline involves a young boy who presents to the ED with increasing pain in his legs.  As they 
progress through the case, initially the boy’s pain is being controlled.  However, he suddenly 
develops a fever and pain symptoms return in another area of the body.  The boy is eventually 
diagnosed with acute chest syndrome and is admitted to the hospital.  There he is placed on a 
PCA (patient-controlled analgesia) and discharged several days later.  Interspersed through the 
case there are several multiple choice questions placed when decisions must be made by the 
learner regarding management of the patient’s pain.  Learners can answer the questions as many 
times as they want and comments are provided as to why an answer was wrong or right.  
Additionally there are two didactic segments, one about pain scales and the other describes co-
morbid conditions that often occur with pain episodes in patients with SCD.   
There were several individuals who were consulted to create a case that would be 
appropriate, realistic and useful for this type of educational intervention.  Dr. Krishnamurti, 
Allison Sakara, CRNP, and Elizabeth Gettig, MS, CGC provided invaluable direction and editing 
expertise.  Dr. James McGee, Director of LET provided essential insight and clarity about 
structure, content and design of educational modalities that make this project work.   
3.1.1 Measuring utility and opinion 
To measure the utility of this educational tool, an evaluation was created to gather information 
(Appendix E).  This information will be invaluable to further refine the focus and style of this 
module, and potentially for similar modules in the future.  The evaluation consists of two 
demographic questions and nine opinion questions.  Demographic information will help 
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determine the population of subjects who are choosing to participate in this activity and also 
estimate level of experience in treating patients with SCD.  There are nine opinion questions that 
ask learners various questions about their attitudes regarding content and style of information 
presented in the module.  Answer choices to eight of nine opinion questions follow a Likert-type 
scale with options ranging between “very low” and “very high”.  The last opinion question asks 
how the learner will alter their management for patients with SCD.  Answer choices range from 
not changing management at all to changing management immediately.  Additionally, there is a 
page for free-text where learners are encouraged to give feedback, insight and comments. 
3.1.2 Measuring Knowledge Gained 
To measure knowledge gained by learners participating in this educational activity, 5 multiple 
choice questions are administered as a pre-test, prior the going through the case, and then as a 
post-test, following completion of the case.  These questions were written as five key ideas that 
the learner should walk away with following the completion of this module.  Questions ask about 
initial evaluation and opioid dosing for a SCD patient presenting to the ED with pain, primary 
goal of pain management in SCD, and assessment and intervention methods. (Appendix F) 
3.1.3 IRB Approval 
This project was submitted for IRB exempt research approval (Appendix B). IRB approval 
number 0702021 was granted, allowing for collection of responses from the pre-test, post-test 
and evaluation.  Prior to each question set, learners were informed of our overall goals with this 
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3.2 
study, and were informed that all information will be kept anonymous and collected for review.  
Additionally, learners are informed of the option to skip the question sets.  
HOSTING OF THE EDUCATIONAL MODULE 
The Laboratory of Educational Technology (LET) is part of the University of Pittsburgh School 
of Medicine.  As medical education increasingly becomes supplemented and enhanced with web-
based technology, the LET was established to address the needs for development of this 
technology.  The LET works directly with the Curriculum Committee, the Office of Medical 
Education, students and faculty of the University of Pittsburgh to create new approaches to 
learning, including computer and web-based solutions.  Dr. James McGee, Director of the LET 
worked with his group to develop a series of web-based initiatives.  Educators and students can 
access a variety of on-line tools to enhance and supplement traditional classroom learning or 
increase collaboration between student researchers and advisors.   
One of the LET’s suite of initiatives includes a collection of web-based virtual patient cases.  
Here we have posted our educational module entitled, “Pain Management in Sickle Cell 
Disease”.  The link to access this module is posted on the Sickle Cell Program web page on the 
CHP’s web site, http://www.chp.edu/centers/03_hema_sickle.php and on PedsEd, an on-line 
resource for health-care providers at CHP, http://pedsed.pitt.edu/06_browse.asp.  PedsEd is also 
supported by individuals in the LET.  Both locations allow for easy access by learners.  Sample 
screen shots of the module are included in this document in Appendix A.  
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3.3 
3.2.1 Data Collection 
For users that access the case via CHP’s Sickle Cell Program web page, the module tallies 
answer selection by users and creates a detailed report with the information summarized.  With a 
log-in and password, access to a detailed report was available at any time to continually monitor 
overall tallies.  For users that access the case via CHP’s PedsEd site, the module tallies answer 
selection by users; however, no detailed report is accessible outside the LET.  To collect data 
from users who access the case here, members of the LET group will pull periodic reports. 
RECRUITMENT 
This educational module was created with the idea that it would be appropriate for any health 
care provider.  To disseminate and advertise the educational module, Dr. Krishnamurti sent 
information and description of the project via e-mail to colleagues within UPMC including 
physicians and faculty in Emergency Medicine and Hematology.  Also, emails were sent out to 
Sickle cell experts outside of Pittsburgh, including clinicians associated with other hospital-based 
Comprehensive Sickle Cell Programs, and clinicians affiliated with the Sickle Cell Disease 
Association of America (SCDAA).  (Appendix C) 
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4.0  
4.1 
RESULTS 
DEMOGRAPHICS AND EVALUATION QUESTIONS 
The results of the evaluation and demographic questions are shown below.  Study subjects gave 
job title, information about number of years experience and opinions regarding this educational 
module.  
 
Table 1. Job Title of Subjects 
Job Title  
Number of 
Subjects Percentage of Subjects 
Resident 3 23.08% 
Fellow 2 15.38% 
Hematology Attending 2 15.38% 
Emergency Medicine Attending 1 7.69% 
Nurse Practitioner/Physician Assistant 2 15.38% 
Genetic Counselor/Social Worker 3 23.08% 
Registered Nurse 0 0.00% 
Psychiatrist/Psychologist 0 0.00% 
Total responses 13   
 
Job title of subjects varied significantly.  Almost 40% of subjects were either fellows or 
attendings.  About 15% of subjects were nurse practitioners or physician assistants, 23% were 
residents, while another 23% were either genetic counselors or social workers.  (Table 1). 
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Table 2. Number of Years Since Highest Degree Acheived 
Number of Years Since Highest 
Degree Achieved Number of Subjects 
Percentage of 
Subjects 
0-3 3 20.00% 
4-6 7 46.67% 
7-9 1 6.67% 
10-14 2 13.33% 
15+ 2 13.33% 
Total responses 15   
 
About 54% of subjects received their highest degree between 4 and 9 years ago. About 27% 
received their highest degree 10 or more years ago, and 20% received their highest degree within 
the last 3 years (Table 2).  
Table 3 summarizes the results from Evaluation Questions 1 through 8.  Evaluation 
question 1 shows 35% of subjects felt that the educational objectives were achieved to a “very 
high” extent.  29% felt they were achieved to a “high” extent, and 35% felt they were achieved to 
a “moderate” extent.  Evaluation question 2 measured subjects’ feelings on the quality of the 
module.  35% were satisfied to a “very high” degree with the quality.  41% felt a “high” degree 
of satisfaction and 24% were “moderately” satisfied with the quality.  Evaluation question 3 
asked if users felt this module was relevant to their practice.  81% of subjects felt that content of 
the educational module was relevant to their practice to a “very high” or “high” degree, and 19% 
felt content was relevant to a “moderate” degree.    Users opinions as to whether they felt a web-
based educational module was useful was solicited in evaluation question 4.  67% of subjects felt 
this type of educational intervention is useful to a “very high” degree.   
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Table 3. Answer Responses to Evaluation Questions 1-8 
Answer Responses % (n) 
  Very Low Low Moderate High Very High Totals 
Evaluation Q1 0 0 35.3% (6) 29.4% (5) 35.3% (6) (17) 
Evaluation Q2 0 0 23.5% (4) 41.2% (7) 35.3% (6) (17) 
Evaluation Q3 0 0 18.8% (3) 43.8% (7) 37.5% (6) (16) 
Evaluation Q4 0 0 20% (3) 13.3% (2) 66.7% (10) (15) 
Evaluation Q5 0 7.7% (1) 53.9% (7) 30.8% (4) 7.7% (1) (13) 
Evaluation Q6 0 50% (6) 25% (3) 8.3% (1) 16.7% (2) (12) 
Evaluation Q7 0 38.5% (5) 53.9% (7) 7.7% (1) 0 (13) 
Evaluation Q8 0 0 63.6% (7) 9.1% (1) 27.3% (3) (11) 
Totals 0 (12) (40) (28) (34)   
 
Evaluation Question 1: To what extent were the educational objectives achieved? 
Evaluation Question 2: To what extent were you satisfied with the overall quality of the educational activity?   
Evaluation Question 3: To what extent was the content of the educational activity relevant to your practice?   
Evaluation Question 4: To what extent do you feel that this type of web-based educational tool is useful?   
Evaluation Question 5: To what extent did the activity enhance your knowledge of treating pain in patients with 
Sickle cell disease?   
Evaluation Question 6: To what extent did the activity change the way you think about treating pain in patients with 
Sickle cell disease?   
Evaluation Question 7: To what extent will you make a change in your practice of treating pain in patients with 
Sickle cell disease as a result of your participation in this educational activity?   
Evaluation Question 8: To what extent did the activity help you to learn and understand the algorithm provided 
(Vasoocclusive Pain in Sickle Cell Disease)? 
 
 
13% felt the intervention was useful to a “high” degree and 20% felt in was “moderately” useful.  
Evaluation question 5 asked subjects the degree to which this educational module enhanced their 
knowledge of pain management in SCD.  8% felt it enhanced their knowledge to a “very high” 
degree, 31% felt the module enhanced their knowledge to a “high” degree and 54% felt this 
educational module enhanced their knowledge to a “moderate” degree.  8% felt the module 
enhanced their knowledge only to a “low” degree.  Evaluation question 6 asked to what extent 
the module changed the way they think about pain management.  17% felt the module changed 
their thinking to a “very high” degree, 8% felt the change was “high”, 25% felt they changed 
their way of thinking to a moderate degree, and 50% reported that this module changed their way 
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of thinking about pain management to a “low” degree.  The next question, evaluation question 7, 
asked to what extent users would implement a change in the way they practice pain management 
in SCD.  8% reported they would change their practice to a “high” degree, 54% felt they would 
change to a “moderate” degree, and 39% reported they would change their practice to a “low” 
degree.  No one felt they would change their practice to a “very high” degree following the use 
of this educational module.  In evaluation questions 5, 6, and 7 several individuals chose the 
“low” answer choice.  These three questions pertained to how much the content of this 
educational module enhanced their existing knowledge of pain management to initiate a change 
in their thinking or practice of pain management.  Evaluation question 8 asked whether the 
educational module helped users to learn and understand the CHP algorithms that were provided.  
About 27% said the module helped to a “very high” degree, 9% said it helped to a “high” degree 
and 67% said it helped to a “moderate” degree.  For all eight evaluation questions, no responded 
that the degree to which something was achieved was “very low”.   
The final evaluation question (Figure 1) asked how learners will change their 
management of pain in patients with SCD.  73% (8/11 responses) said they “will not change, 
because they are treating in accordance with the algorithm.  9% (1/11 responses) said they would 
“need more information before they make a change” in practice, and 18% (2/11 responses) said 
they would “immediately change” their management of pain in patients with SCD. 
 
Which Best Describes the Impact of This Activity 
on How You Will Manage Pain in SCD?
73%
0%
9%
18%
1. will not  change, I treat same
as module
2. will not  change, I don’t
agree with module
3. I need more info before I
change
4. I will immediately change
 
Figure 2. Evaluation Question 9 
4.2 KNOWLEDGE QUESTIONS 
The knowledge questions were written to determine whether there was a shift understanding of 
the basic principles of treating a patient with SCD in the ED.   
 
Table 4. Answer Selection to Knowledge Questions 
 #correct/ #incorrect (%correct) #correct/ #incorrect (%correct) 
  Pre-Test Post-Test 
Knowledge Question 1 12/20 (60%) 7/13 (54%) 
Knowledge Question 2 16/19 (84.2%) 12/13 (92.3%) 
Knowledge Question 3 16/17 (94.1%) 13/13 (100%) 
Knowledge Question 4 7/16 (53.3%) 9/13 (69.2%) 
Knowledge Question 5 12/17 (70.6%) 13/13 (100%) 
See Appendix F for knowledge questions and answer options. 
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Knowledge question 1 asks the learner what should be evaluated for when a patient with 
SCD presents to the ED with pain and fever.  The correct response is that complications 
associated with Sickle cell disease and also other common medical problems should be 
considered.  In the pre-test, answers were given for all choices available with 60% answering the 
question correctly.  25% felt that only the common co-morbidities should be evaluated for, 10% 
felt in this scenario only common medical or surgical complications should considered, and 5% 
thought it likely that this patient was attempting to obtain more pain medication.  Interestingly, in 
the post-test the number of subjects choosing the right answer decreased to 54%, with 46% of 
subjects choosing evaluation of common complications of Sickle cell disease only as the correct 
answer. 
Knowledge question 2 asks the best way to determine initial dosing of pain medications 
for patients with SCD.  The correct response is to follow the patients established Individualized 
Management Plan or the institutional guidelines for treating pain in patients with SCD.  About 
84% of pre-test subjects chose the correct answer.  Approximately 5% of pre-test subjects felt 
that all SCD patients should receive the same management with IV fluids, oxygen and Ketorolac 
followed by a 2 hour interval to determine if opioids should be considered.  Another 5% of pre-
test subjects felt the patient should receive what they were taking at home for pain.  The 
remaining 5% felt that dosing should start at the low end of the range for body weight and age.  
92% of post-test subjects chose the correct response, with 8% feeling the patient should continue 
to receive what they were taking at home. 
Knowledge question 3 asks learner what they think the overall goal is for treating pain in 
patients with SCD presenting to the ED with a pain episode and how the role of opioids 
administration should be approached.  The correct answer is “aggressive management of pain in 
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a supportive environment can lead to relief of pain and obviate the need for hospitalization in a 
substantial proportion of patients”.  About 94% of pre-test subjects answered correctly, with the 
remaining 6% of pre-test subjects feeling that opioids should be restricted for this patient 
population due to concerns for developing drug dependence and tolerance.  100% of post-test 
subjects answered this question correctly. 
Knowledge question 4 asks what the intervals should be for administering pain 
medications to a patient with SCD who is experiencing a pain episode.  The correct response is, 
“peak effect of morphine occurs in 20 minutes. Based on patient response, doses can be repeated 
at that interval”.  About 56% of pre-test subjects answered correctly.  19% of pre-test subjects 
thought the correct response was that pain medications can be administered every 3-5 hours, 
another 19% thought it was dependent on whether the patient was a child or an adult, and about 
6% felt all patients with SCD should receive fixed doses of Demerol.  There was an increase to 
69% giving the correct response in the post-test.  Additionally, 8% still felt that intervals were 
every 3-5 hours, and 23% thought it was dependent on whether it was a pediatric or adult patient. 
Knowledge question 5 asks about the best way to assess the patient’s response to current 
management of pain.  About 71% of pre-test subjects answered correctly, feeling the best way to 
make this determination is by self-report by the patient.  12% thought the best way would be 
through nursing staff observation of patient activity, and 18% thought consideration of clinical 
assessment, vital signs and laboratory markers for inflammation was the most appropriate way.  
100% of post-test subjects answered this question correctly. 
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5.0  
5.1 
DISCUSSION 
DEMOGRAPHICS 
Demographic information obtained in this project was limited to job title and number of years 
since highest degree was achieved.  Collecting this information roughly determines the amount 
of past experience of our study population.  In both measures, the study population is quite 
varied.  This is advantageous for patients in that increased knowledge of effective pain 
management by all health-care providers who care for patients with SCD will yield better overall 
care.  A varied study population can also have an impact on degree of knowledge gained.  
Understandably, an Emergency Medicine attending is going to have more experience in pain 
management and therefore higher preliminary knowledge of pain management than a social 
worker.  On the other hand, individuals who have been practicing for many years may be more 
reluctant to change their current practices.  For example, if a physician has been under the 
assumption that patients with pain should be reassessed at the medication’s estimated half-life 
for the last 10 years, it may take more effort to convince them to begin to reassess at the 
medication’s peak effect instead.  It may be easier to influence practice among health-care 
providers who are earlier in their career and still developing their skill sets.   
Recruitment for subjects to participate involved distribution of an email describing our 
efforts and asking for recipient participation as well as asking recipients to recruit their 
 38 
 
5.2 
colleagues to also participate in our educational module.  Email recipients included Hematology 
and Emergency Medicine faculty within University of Pittsburgh Medical Center (UPMC) and 
also to Sickle cell experts outside of Pittsburgh, including clinicians associated with other 
hospital-based Comprehensive Sickle Cell Programs, and clinicians affiliated with the Sickle 
Cell Disease Association of America (SCDAA).  While this population of individuals likely 
already has strong understanding of effective pain management, they provide valuable feedback 
to help future refinement of the module. 
AIM 1: ASSESS WHETHER HEALTH CARE PROVIDERS HAVE INCREASED 
KNOWLEDGE OF MANAGEMENT ACUTE PAIN FROM VASO-OCCLUSION IN 
PATIENTS WITH SCD 
To determine whether this objective was achieved, evaluation question 5, “To what extent did 
the activity enhance your knowledge of treating pain in patients with Sickle cell disease?” and 
answer selection from the pre and post test knowledge questions were considered. 
Answers from evaluation question 5 ranged from “low” enhacement of knowledge to a “very 
high” degree of enhancement of knowledge, with the vast majority (84%) feeling knowledge 
enhancement was to a “moderate” or “high” degree.  This variability in responses likely reflects 
the variety of background knowledge that our subjects have.  Although it is somewhat reassuring 
that subjects feel that they have some enhancement of knowledge, results from the pre and post 
test indicate there are some individuals who have not incorporated some of the most important 
teaching points.  This indicates that refinement in our educational module is required.  
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Additionally, not surprisingly, it is clear that there is a high level of preliminary knowledge in 
this subject population.  As a result, there is not a sharp shift in knowledge gained.  Assessment 
of knowledge gained is also limited by a small sample size and differing sample size from pre-
tests (about 20) to post-tests (13). 
There was general improvement number of correct responses from the pre-test to the 
post-test in 4 out of 5 knowledge questions. Surprisingly there were fewer correct responses on 
the post-test than on the pre-test for Knowledge Question 1, “A patient with SCD presenting with 
fever and chest or abdominal pain should be evaluated for which of the following?”  The correct 
response is that the patient should be evaluated for the common co-morbidities associated with 
SCD (like acute chest syndrome and splenic sequestration); however, a patient with SCD should 
also be evaluated for other causes of pain that are commonly seen in any patient who presents 
with these symptoms, like appendicitis.  In the post-test a majority of subjects did choose the 
correct response (54%), however the remainder of post-test subjects (46%) thought the correct 
answer was answer 1, to monitor only for common SCD co-morbidites.  This lowered the 
percentage of correct responses from 60% in the pre-test to 54% in the post-test.  There are 
several possible explanations for this unexpected, post-test response.  The storyline presented in 
the educational module, describes how the patient, Terrell, ended up with actue chest syndrome.  
Additionally there is a didactic segment reinforcing the importance of monitoring for co-morbid 
conditions like acute chest syndrome in patients with SCD.  Furthermore, the physical exam that 
was performed on Terrell upon his acute abdominal pain symptoms may not have been sufficient 
to drive home the point that patients must still be monitored for any cause of his pain symptoms.  
This unexpected twist displayed in knowledge question 1 is an indication that time must be spent 
re-writing this portion of the case to clarify the need to monitor patients with SCD for other 
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causes for their symptoms that are unrelated to their disease.  Lastly, fewer subjects actually took 
the post-test than the pre-test.  It is possible that learners who accurately knew the pre-test 
answers chose not to take the time to take the post-test, shifting the post-test study population to 
a group with less experience in this scenario that may not pick up on the reasoning for the 
additional physical exam described in the case. 
Knowledge question 2 and knowlegde question 3 showed similar findings.  Question 2 
asked what was the best way to determine initial dosing of pain medications for SCD patients.  
Question 3 asked what the goal of pain management was and what role opioids play in treating 
pain episodes in patients with SCD.  The vast majority of the pre-test population correctly 
answered both questions, with slightly more answering correctly in the post-test.  These 
questions show that there is high preliminary knowledge that using Indiviudalized Management 
Plans or institutional guidelines are the most effective methods for initial dosing, and that the 
overall goal of pain management is that aggressive treatment of pain episodes can help to reduce 
hospitalizations in this patient population. 
Knowledge question 4 asked about the intervals for administration of pain medications, 
and yielded the most varied answer responses among the pre-test population.  The most common 
answer in the pre-test was the correct response, that administration intervals follow assessment of 
patient’s pain every 20 minutes.  Post-test performance was improved, with 13% more subjects 
answering correctly.  However, aside from knowledge question 1, question 4 had the highest 
post-test responses incorrect (31%).  This is somewhat troubling as a great effort was made to 
reinforce constant reassessment of patient pain every 15-30 minutes to determine follow-up 
dosing.  These persistant wrong answers could be a result of the wording of the question.  
Perhaps instead of “…at what intervals can pain medications be administered…” the question 
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should be more complete and read, “…at what intervals should a patient be reassessed to 
determine what follow-up doses should be administered…”.   Or, perhaps there should be more 
emphasis in the case that reassessment of the patients pain level every 15-30 minutes should 
involve administration of more pain medications if pain has not shown improvement.  Changing 
wording within the case and for this knowledge question may drive home the point that 
management must involve patient input and should be aggressive.   
Knowledge question 5 showed the biggest shift in correct responses between the pre-test 
(62%) and post-test (100%).  This shift in knowledge could have been enhanced due to a similar 
question embedded within the case, that asked whether Terrell should be awoken to assess his 
pain, the answer was yes, he should.  Another consideration for the nice improvement in correct 
responses could be a result of how the question was worded.  Of all the knowledge questions it is 
the most succintly written, without room for misinterpretation. 
Based on responses to evaluation question 5, a majority of subjects felt their level of 
knowledge of pain management was enhanced to some degree.  However, answer selection from 
the pre and post test show that there remains room for improvement of knowledge.  This will be 
achieved by careful re-wording of the knowledge questions, and deeper explanation of key 
learning points that were not adequately described or explicitly stated.  
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5.3 AIM 2: DETERMINE WHETHER HEALTH CARE PROVIDERS WILL ALTER 
THEY WAY THEY MANAGE PATIENTS WITH SCD PRESENTING TO THE ED OR 
TO THEIR CLINICAL PRACTICE WITH PAIN FOLLOWING THE USE OF THIS 
EDUCATIONAL MODULE 
To elucidate whether subjects would change their approach or pratice of managing pain in 
patients with SCD examination of responses to evaluation question 6, “To what extent did the 
activity change the way you think about treating pain in patients with Sickle cell disease?”, 
evaluation 7, “To what extent will you make a change in your practice of treating pain in patients 
with Sickle cell disease as a result of your participation in this educational activity?”, and 
evaluation question 9, “Which of the following best describes the impact of this activity on how 
you will treat pain in patients with Sickle cell disease?” were considered.   
As described above study subjects did indicate some enhanced kowledge.  However, 
enhancement of knowledge did not cause a change in the way subjects thought about pain 
management.  50% of subjects felt they thought differently about pain management only to a 
“low” degree.  Another 25% felt their change in practice would be to a “moderate” degree.  The 
remaining 25% thought differently to a “high” or “very high” degree.  An explanation for the 
many “low” or “moderate” answers is that this particular question could have been interpreted as 
whether the module altered attitudes toward treating pain managmement in patients with SCD, or 
altered future approach of treating pain.  Evaluation question 6 would provide more information 
if it was re-worded to specifically ask about subjects attitudes about managing pain in patients 
with SCD.   
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5.4 
Evaluation question 7 asks whether the subject will change the way they practice pain 
management.  92% said they would make a “low” or “moderate” change in practice.  Given the 
moderate shifts in knowledge and mind-set of pain management, it is not surprising that subjects 
indicate minor changes in their practice of pain management as well.   Evaluation question 9 asks 
subjects to describe how and why practice will or will not change following this educational 
activity.  73%  (8/11 responses) said they will not change because they are already practicing as 
the educational module recommends.  While this is reassuring information, it could indicate 
sample bias amoung our subjects.  Our recruitment methods included dissemination of this 
module to various groups and institutions who tend to be well versed in the most up-to-date 
treatment practices for SCD and the best pain management recommendations.  Indeed, the 
treatment protocol described in our educational module, and the algorithm created by the CHP 
Comprehensive Hemoglobinopathy Program, is compiled by the latest and most recent 
recommendations by experts in the field of SCD.   
AIM 3: TO DETERMINE HEALTH CARE PROVIDERS OVERALL 
ATTITUDES ABOUT WEB-BASED EDUCATIONAL MODULES 
A majority (41%) of subjects were satisified with the overall quality of the educational module to 
a “high” degree, followed by 35% who were satisfied to a “very high” degree.  24% of subjects 
were satisfied with the quality to a moderate degree.  Similar responses were given when asked 
about the relevance of the content of the educational module to subjects’ practice, with 81% of 
subjects feeling content was relevant to a “very high” or “high” degree.  Additionally, 80% of 
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5.5 
subjects felt that this type of web-based education was useful to a “very high” or “high” degree.  
Of note, more subjects indicated that the felt web-based modules were useful than there were 
subjects who felt they had gained knowledge by using this module.  This information is 
significant; despite variable degrees of knowledge enhancement, subjects indicated that this type 
of educational tool is well received by learners.  This is promising that as content refinement 
continues, learners will also continue to take advantage of this educational application. 
AIM 4: ASSESS WHETHER THIS TYPE OF EDUCATIONAL TOOL HELPED 
PROVIDERS TO LEARN AND UNDERSTAND THE ESTABLISHED CHP 
ALGORITHM FOR MANAGING VASOOLUSIVE PAIN IN PATIENTS WITH SICKLE 
CELL DISEASE 
64% of subjects reported a “moderate” shift in learning and understanding the CHP algorithm for 
managing pain in SCD.  The remaining 36% felt the module help to understand the algorithm to 
a “very high” or “high” degree.  When asked whether the educational objectives were achieved 
in the module, 36% subjects reported the objectives were at least “moderately” achieved, the 
remaining subjects felt the objective were achieved to a “high” or “very high” degree.  We were 
expecting similar responses to these two evaluation questions as the educational objectives were 
based on the algorithm.  The difference between responses to these questions may be due to the 
fact that the learning objectives were clearly listed on one of the first slides of the module.  The 
algorithm is given in the form of a PDF link and users are asked to refer to it while going through 
the case.  It is possible, although unlikely, that some users do not have software like, Adobe on 
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5.6 
their computers and were therefore unable to access the algorithm.  More likely is the possibility 
that the algorithm is not being printed by all subjects and is instead glanced over briefly by the 
learner.  Due to the degree of information in the algorithm, a one-time glance may not be enough 
to grasp all the content included in this algorithm.  Manipulations to the module in the future 
could include a way to provide access to the algorithm periodically throughout the module.  
Additionally, the number of “moderate” responses indicates that there are topics that must be 
expanded upon in order to clarify the algorithm and learning objectives.  
LIMITATIONS AND OTHER CONSIDERATIONS 
The announcement of the availability of this educational module for health-care providers 
(potential study subjects) began on March 8, 2007, leaving about three weeks for data collection.  
As a result there is a very small sample size with number of subjects varying with each question, 
ranging from 11-20 responses.  The limited number of responses makes it difficult to interpret 
the data collected thus far.  The case will remain accessible via CHP’s Sickle Cell Program web 
page and on the PedsEd site at least for the next year.  Furthermore, the case can be located on 
Google as the second, third, and fourth response by searching, “sickle cell Pittsburgh”.  It is our 
hope that this wide accessibility to the case will allow for continual data collection.     
In order to maintain IRB requirements, including anonymity and option to not participate, 
users were able to skip any questions they wanted.  Due to the nature of a web-based application, 
and the fact that our subjects are health-care providers, it is not difficult to imagine how often 
someone may be interrupted, and for whatever reason fail to answer all the questions asked.  In 
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an effort to maintain anonymity and provide easy, quick access to the module, learners were not 
required to log-in to the educational module or to PedsEd to access the case. 
Not requiring learners to log-in to the educational module does provide anonymity and 
easy access for learners.  However, this feature also prevents the ability to follow one learner’s 
responses through the entire module; from pre-test, to post-test, through the evaluation.  The 
programming necessary to create the custom reports that could follow individual users, simply 
would take too much time to create, or would inevitably require users to log-in with a disclaimer 
that their information would be de-identified prior to data collection.  In either case, we would 
loose some of our study population.       
The inability to track one learners answer responses through the module is limiting for 
two reasons.  First, it prevents the ability to make any conclusions about whether certain answer 
choices track with demographic information, or work experience.  Second, we are unable to see 
how individuals improved with the knowledge questions.  Clearly there are more answer 
responses for the pre-test, than for the post-test.  If we had been able to track individuals we 
would also be able to see if there was any correlation between pre-test scores and not completing 
the remainder of the questions.  Without being able to track demographic information and pattern 
of responses or measure individual learner’s pre and post test scores, we were unable to perform 
any statistical analysis.            
As previously mentioned, in an effort to disperse this educational module to as many 
clinicians as possible, the range of background knowledge varies a great deal.  By dispersing this 
educational tool to many health care providers, we are able to receive feedback from individuals 
with various perspectives, which is essential.  On the other hand it becomes difficult to interpret 
data, especially in light of our small sample size.  For example, were the four individuals who 
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5.7 
continued to get knowledge question 4 wrong in the post-test answered by individuals who 
received their medical or nursing degree last year, or were they answered by Hematology 
attendings.  The answer has very different implications. 
Much of our recruitment information went out to health care providers who are experts in 
the field.  Although this ensures useful and constructive feedback, it does add the potential 
sample bias by a population of subjects that are SCD experts.  Looking forward, as our subject 
population increases it would be of interest to determine how comfortable health care providers 
feel treating pain in SCD and administering opioids prior to participating in this educational 
module and then ask a similar question at the completion of the module.  This would determine 
whether confidence level in treating patients with opioids and relates to level of knowledge. 
FUTURE STUDIES 
Moving forward, we will continue to refine case content, as well as in the way the knowledge 
and evaluation questions are written.  Content of the case will be improved to increase 
delineation of teaching points, and to reinforce learning objectives. Both knowledge and 
evaluation questions will be edited to allow for more succinct, concise, and relevant questions.   
Other areas that could be addressed involve the technology side of the educational 
module.  We will have to determine a method to track each learner’s responses without using 
their personal information and maintaining ease of use of the module.  Perhaps each user could 
be assigned an ID as soon as they answer the first knowledge pre-test question, or instead 
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learners could be asked to give themselves any name or ID on the same screen where the learner 
is told to imagine they are a pediatric Emergency Medicine resident.   
To increase awareness and understanding of Children’s Hospital of Pittsburgh’s 
Guidelines for Clinical Effectiveness for managing pain from vaso-occlusion in patient’s with 
Sickle cell disease, we will provide continued access to the algorithm throughout the case.  This 
will provide convenient availability of the algorithm as learners answer the question sets. 
Currently, learners are given the option to not respond to some or any questions asked in 
order to comply with IRB research requirements.  While we continue to collect data, consent for 
participation by the learner will be elicited prior to beginning the module.  Once an learner has 
agreed to participate they will be required to answer all questions.  In addition, the post-test 
questions may be moved from their current location at the very end of the case to interspersing 
them throughout the case, much the informational, embedded questions.  By inserting the post-
test questions within the case where the correct answer is being discussed will put the question in 
context, and provide reinforcement of that particular teaching point. 
In the future, it is possible that this module or modules similar to this one could be 
incorporated into medical school curriculums, or available for continuing education credits.  In 
either of these scenarios, users will be required to answer all questions within the module.  This 
paired with the ability to track one subject’s answer responses will allow for more complete and 
accurate data analysis. 
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6.0  CONCLUSIONS 
Subjects achieved moderate enhancement of knowledge following the use of this educational 
module.  Due to the limitations in this study it is difficult to distinguish if this is because learners 
had a high level of preliminary knowledge, if the pre and post test subject populations varied 
significantly in their background knowledge, or if it is tied to the wording of case content or the 
questions asks.  To eliminate one of these possibilities efforts will involve revisions in the case to 
clarify and emphasize teaching points, and re-wording to streamline questions.   
The majority of subjects indicated that they would make few changes in the way they 
actively manage pain in patients with SCD.  This coincides with moderate gains in knowledge 
and in understanding of the CHP algorithm (Guidelines for Clinical Effectiveness) for managing 
vaso-occlusive pain in SCD patients.  Interestingly, most learners feel they are already treating 
patients in the manner described by our project.  Again, this indicates efforts must be spent 
reinforcing the primary learning objectives of our educational module.  Subjects did indicate that 
they felt that the module was of good quality, relevant to their work, and felt is was a useful 
mode of education.   
Based on the information provided by this project, an interactive web-based educational 
module can enhance health-care providers’ knowledge of pain management in SCD with 
additional efforts to improve content and question sets.  A web-based application is appealing to 
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learners, and can aid in providers becoming more familiar with the institutional Guidelines for 
Clinical Effectiveness.   
From a public health perspective, undertreatment of pain in health care settings is a major 
problem. In SCD, undertreatment of pain episodes causes increased hospital admission rates and 
decreased overall quality of life.  Poorly managed pain in SCD can affect both physical and 
emotional well-being.  Enhancing health-care providers’ knowledge and awareness of effective 
methods of managing pain in SCD is the key to beginning to alleviate this problem.  As health 
care providers improve their practices, patient anxiety will reduce, hospitalizations will decrease, 
and inevitably, quality of life will improve for many patients.   
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APPENDIX B 
IRB APPROVAL LETTER 
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APPENDIX C 
RECRUITMENT E-MAIL 
Dear Colleague, 
 
In an effort to facilitate efficient and effective pain management in patients with Sickle cell 
disease, we have created a comprehensive, web-based educational module for use by all health care 
providers who treat pain in patients with this complex disease.  
 
The module provides an instantaneous link to peer reviewed information to effectively treat pain 
episodes in patients with Sickle cell disease.  Users will follow a virtual clinic experience of a child with 
Sickle cell disease presenting to the Emergency Department with pain, and will learn to successfully 
manage his current pain episode.  Users are asked to complete a brief test of knowledge of the key 
principles of vaso-occlusive pain management for a patient with sickle cell disease presenting to the 
Emergency Department.  Once completing the module the user will be requested to complete it again. We 
also request that they complete a brief evaluation and invite additional feedback to determine overall 
opinion about this type of educational tool.  
 
We are asking that you encourage your colleagues and other health care providers (including 
attending physicians, fellows, residents, nurses, psychologists, social workers, etc.) to take advantage of 
this unique educational opportunity. 
 
Information gathered in the pre and post test and evaluation tool are collected anonymously and 
will be used for refinement and further improvement of this educational module.  
 
Please visit our educational module entitled, “Pain Management in Sickle Cell Disease” by 
clicking on the link provided on the Children’s Hospital of Pittsburgh’s Sickle Cell Program web-page at 
http://www.chp.edu/centers/03_hema_sickle.php.  If you are a pediatric resident at Children’s hospital of 
Pittsburgh you will be able to access this case from the PedsEd site under the heading, Pediatric 
Hematology. 
 
Thank you.  We look forward to your participation and feedback. 
 
Sincerely, 
Lakshmanan Krishnamurti, MD 
Director, Comprehensive Hemoglobinopathy Program 
Division of Pediatric Hematology/Oncology 
Associate Professor of Pediatrics, University of Pittsburgh School of Medicine 
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APPENDIX D 
CHP ALGORITHM FOR PAIN MANAGEMENT OF SCD PATIENT WITH PAIN IN 
THE ED 
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APPENDIX E 
EVALUATION TOOL 
Demographic Question 1 
Job title 
1. Resident 
2. Fellow 
3. Hematology Attending 
4. Emergency Medicine Attending 
5. Nurse Practitioner/Physician Assistant 
6. Registered Nurse 
7. Genetic Counselor/Social Worker 
8. Psychiatrist/Psychologist  
 
Demographic Question 2 
Number of years since receiving highest degree 
1. 0-3 
2. 4-6 
3. 7-9 
4. 10-14 
5. 15+  
 
Evaluation Question 1 
To what extent were the objectives of the educational activity achieved? 
1. Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High 
 
Evaluation Question 2 
To what extent were you satisfied with the overall quality of the educational activity? 
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1.   Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High  
 
Evaluation Question 3 
To what extent was the content of the educational activity relevant to your practice? 
1. Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High  
 
Evaluation Question 4 
To what extent do you feel that this type of web-based educational tool is useful? 
1. Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High 
 
Evaluation Question 5 
To what extent did the activity enhance your knowledge of treating pain in patients with Sickle 
cell disease? 
1. Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High (e5) 
 
Evaluation Question 6 
To what extent did the activity change the way you think about treating pain in patients with 
Sickle cell disease? 
1. Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High  
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Evaluation Question 7 
To what extent will you make a change in your practice of treating pain in patients with Sickle 
cell disease as a result of your participation in this educational activity? 
1. Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High  
 
Evaluation Question 8 
To what extent did the activity help you to learn and understand the algorithm provided 
(Vasoocclusive Pain in Sickle Cell Disease)? 
1. Very Low 
2. Low 
3. Moderate 
4. High 
5. Very High 
 
Evaluation Question 9 
Which of the following best describes the impact of this activity on how you will treat pain in 
patients with Sickle cell disease? 
1. This activity will not change my behavior because I am currently treating pain in Sickle 
cell patients in a manner consistent with the information that was provided. 
2. This activity will not change the way I treat patients with Sickle cell disease because I do 
not agree with the information provided. 
3. I need more information before I change the way I treat pain in patients with Sickle cell 
disease. 
4. I will immediately implement the information provided in the activity. 
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APPENDIX F 
KNOWLEDGE QUESTIONS 
Knowledge Question 1 
A patient with Sickle cell disease presenting with fever and chest or abdominal pain should be 
evaluated for which of the following?  
1. Sickle cell related complications such as acute chest syndrome or splenic sequestration. 
2. Other medical or surgical problems such as appendicitis or peptic ulcer. 
3. This patient is likely attempting to obtain more pain medications by complaining of chest 
pain. 
4. 1 and 2 above.  
 
Knowledge Question 2 
What is the best way to determine initial dosing of pain medications for patients with Sickle cell 
disease? 
1. All patients should receive IV fluids, oxygen and Ketorolac. If there is no response 2 
hours after these medications have been administered, opiates may be considered. 
2. Ask the patient what they took at home and continue to give them the same. 
3. Follow the patient's established Individualized Management Plan or adhere to 
institutional guidelines for treating pain in patients with Sickle cell disease. 
4. Dose at the low end of the range for age and body weight.  
 
Knowledge Question 3 
Which of the statements below correctly describes the goal of pain management and role of 
opioid use in patients with Sickle cell disease who present to the ED with pain from 
vasoocclusion? 
1. Many patients with Sickle cell disease exhibit drug seeking behavior. It is important to 
minimize exposure to opioids to prevent drug addiction 
2. Aggressive management of pain in a supportive environment can lead to relief of pain 
and obviate the need for hospitalization in a substantial proportion of patients 
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3. Aggressive use of opioids carries the risk of respiratory suppression and sudden death in 
patients with Sickle cell disease and should be discouraged 
4. Patients with Sickle cell disease have a life long need for opioids and dosing should be 
restricted to the lower end of the range to prevent tachyphylaxis and drug dependence 
 
Knowledge Question 4 
At what intervals can pain medications be administered to a patient with Sickle cell disease 
presenting to the ED in a pain episode? 
1. Since the duration of effect of morphine is 3-5 hours, doses can be repeated at that 
interval 
2. Since the half life of morphine is 1-2 hours in children and 2-4 hours in adults, doses can 
be repeated at that interval 
3. Any patient with Sickle cell disease coming to the ED should be given three fixed doses 
of Demerol at 2 hour intervals 
4. Peak effect of morphine occurs in 20 minutes. Based on patient response, doses can be 
repeated at that interval 
 
Knowledge Question 5 
What is the best way to assess patient response to current management of pain? 
1. The patient's self-report of efficacy of treatment 
2. Patients with Sickle cell disease frequently exhibit drug seeking behavior. Treatment 
should be by a strict pain management contract regardless of clinical observation or 
patient report 
3. Observation of the patient's activity and sleep pattern as reported by the nursing staff 
4. Combination of clinical assessment, vital signs and laboratory signs of acute 
inflammation 
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